Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 31;22(15):8278.
doi: 10.3390/ijms22158278.

Biofilms in Diabetic Foot Ulcers: Impact, Risk Factors and Control Strategies

Affiliations
Review

Biofilms in Diabetic Foot Ulcers: Impact, Risk Factors and Control Strategies

Ana C Afonso et al. Int J Mol Sci. .

Abstract

Diabetic foot ulcers (DFUs) are a serious complication from diabetes mellitus, with a huge economic, social and psychological impact on the patients' life. One of the main reasons why DFUs are so difficult to heal is related to the presence of biofilms. Biofilms promote wound inflammation and a remarkable lack of response to host defences/treatment options, which can lead to disease progression and chronicity. In fact, appropriate treatment for the elimination of these microbial communities can prevent the disease evolution and, in some cases, even avoid more serious outcomes, such as amputation or death. However, the detection of biofilm-associated DFUs is difficult due to the lack of methods for diagnostics in clinical settings. In this review, the current knowledge on the involvement of biofilms in DFUs is discussed, as well as how the surrounding environment influences biofilm formation and regulation, along with its clinical implications. A special focus is also given to biofilm-associated DFU diagnosis and therapeutic strategies. An overview on promising alternative therapeutics is provided and an algorithm considering biofilm detection and treatment is proposed.

Keywords: biofilms; chronic wounds; combination therapy; multidrug resistance; pathophysiology; polymicrobial aetiology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Clinical and laboratory indications for diagnosis of biofilm infections—ESCMID General Features. Based on Høiby et al. [124].

Similar articles

Cited by

References

    1. American Diabetes Association Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2013;37:S81–S90. doi: 10.2337/dc14-s081. - DOI - PubMed
    1. Mukhtar Y., Galalain A.M., Yunusa U.M. A Modern Overview on Diabetes Mellitus: A Chronic Endocrine Disorder. Eur. J. Biol. 2019;4:1–14.
    1. Katsarou A., Gudbjörnsdottir S., Rawshani A., Dabelea D., Bonifacio E., Anderson B.J., Jacobsen L., Schatz D.A., Lernmark Å. Type 1 diabetes mellitus. Nat. Rev. Dis. Prim. 2017;3:nrdp201716. doi: 10.1038/nrdp.2017.16. - DOI - PubMed
    1. Chatterjee S., Khunti K., Davies M.J. Type 2 diabetes. Lancet. 2017;389:2239–2251. doi: 10.1016/S0140-6736(17)30058-2. - DOI - PubMed
    1. Coustan D.R. Gestational Diabetes Mellitus. Clin. Chem. 2013;59:1310–1321. doi: 10.1373/clinchem.2013.203331. - DOI - PubMed